ArticleAnnals of surgical oncology2025

ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?

Takumi Sato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.